Grail
GRAIL, Inc. is a healthcare company headquartered in Menlo Park, California, focused on detecting cancer early, when it can be cured. Its flagship product, the Galleri multi-cancer early detection (MCED) test, uses a single blood draw and methylation-based genomic sequencing to screen for a signal shared across more than 50 types of cancer, many of which lack any recommended screening today. GRAIL runs large clinical programs including the PATHFINDER, PATHFINDER 2, and NHS-Galleri studies, and distributes Galleri through health plans, employers, and partners such as Quest Diagnostics and Junction. GRAIL is a portfolio company of investors including GV and SV Angel. It does not publish a first-party public developer API; programmatic access to Galleri ordering is offered through third-party diagnostic infrastructure partners.
Grail is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Healthcare, Cancer Detection, and Diagnostics.
Grail’s developer surface includes engineering blog, support, and 5 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API